Skip to content
Disclosery

Sivik Global Healthcare LLC

Follow

13F filer, CIK 1596452, GREENWICH, CT

Sivik Global Healthcare LLC reported $175,040,173 across 35 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-10-13. Its ten largest share positions make up 46.25% of the portfolio.

Accepted , ingested 13F-HR 0001596452-26-000008

Period
2026-09-30
Reported value
$175M
Holdings
35
Top 10 weight
46.25%
New
12
Sold out
11

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CNCnew+80,000$4.97M
XBIadded+30,000$4.73M
RVTYnew+30,000$4.59M
BRKRnew+65,000$4.21M
MDTnew+45,000$3.88M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CALL- BSX 100 @ 75 EXP 04/…exited-800-$5.02M
ISRGexited-9,000-$4.15M
AZNexited-20,000-$3.94M
BSXexited-62,000-$3.89M
THCexited-20,000-$3.77M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001596452-26-000008, largest first. % of portfolio is the value over $175,040,173, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
XBISPDR SERIES TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 200,000 shares; 2025Q1: 250,000 shares; 2025Q2: 250,000 shares; 2025Q3: 250,000 shares; 2025Q4: 225,000 shares; 2026Q1: 150,000 shares; 2026Q2: 150,000 shares; 2026Q3: 180,000 shares 180,000$28.4M16.21%+30,000Timeline
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 20,000 shares; 2025Q1: 23,000 shares; 2025Q2: 27,000 shares; 2025Q3: 25,000 shares; 2025Q4: 15,000 shares; 2026Q1: 20,000 shares; 2026Q2: 20,000 shares; 2026Q3: 17,700 shares 17,700$6.75M3.86%-2,300Timeline
JNJJOHNSON & JOHNSONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 25,000 shares; 2025Q4: not reported; 2026Q1: 20,000 shares; 2026Q2: 20,000 shares; 2026Q3: 24,000 shares 24,000$6.35M3.63%+4,000Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: 40,000 shares; 2026Q2: 40,000 shares; 2026Q3: 40,000 shares 40,000$5.81M3.32%0Timeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 25,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 20,000 shares; 2025Q4: 20,000 shares; 2026Q1: 15,000 shares; 2026Q2: 15,000 shares; 2026Q3: 22,000 shares 22,000$5.75M3.29%+7,000Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 14,000 shares; 2025Q4: 12,000 shares; 2026Q1: 8,000 shares; 2026Q2: 8,000 shares; 2026Q3: 8,500 shares 8,500$5.74M3.28%+500Timeline
CAHCARDINAL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 50,000 shares; 2025Q1: 50,000 shares; 2025Q2: 45,000 shares; 2025Q3: 37,500 shares; 2025Q4: 32,500 shares; 2026Q1: 24,000 shares; 2026Q2: 24,000 shares; 2026Q3: 25,000 shares 25,000$5.56M3.18%+1,000Timeline
MCKMCKESSON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 15,000 shares; 2025Q1: 11,000 shares; 2025Q2: 13,000 shares; 2025Q3: 7,000 shares; 2025Q4: 9,000 shares; 2026Q1: 4,000 shares; 2026Q2: 4,000 shares; 2026Q3: 6,500 shares 6,500$5.55M3.17%+2,500Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 25,000 shares; 2025Q1: 35,000 shares; 2025Q2: 40,000 shares; 2025Q3: 35,000 shares; 2025Q4: 23,000 shares; 2026Q1: 20,000 shares; 2026Q2: 20,000 shares; 2026Q3: 25,000 shares 25,000$5.54M3.16%+5,000Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,500 shares; 2025Q1: 5,000 shares; 2025Q2: 15,000 shares; 2025Q3: 12,000 shares; 2025Q4: 12,000 shares; 2026Q1: 10,000 shares; 2026Q2: 10,000 shares; 2026Q3: 15,000 shares 15,000$5.51M3.15%+5,000Timeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 13,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 14,000 shares; 2025Q4: 13,770 shares; 2026Q1: 10,000 shares; 2026Q2: 10,000 shares; 2026Q3: 10,500 shares 10,500$5.49M3.14%+500Timeline
ELVELEVANCE HEALTH INC FORMERLYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,000 shares; 2026Q2: 5,000 shares; 2026Q3: 14,000 shares 14,000$5.44M3.11%+9,000Timeline
ABTABBOTT LABORATORIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 50,000 shares; 2025Q1: 45,000 shares; 2025Q2: 39,200 shares; 2025Q3: 37,500 shares; 2025Q4: 40,000 shares; 2026Q1: 25,000 shares; 2026Q2: 25,000 shares; 2026Q3: 55,000 shares 55,000$5.44M3.11%+30,000Timeline
CORCENCORA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 25,000 shares; 2025Q1: 25,000 shares; 2025Q2: 25,000 shares; 2025Q3: 20,000 shares; 2025Q4: 18,000 shares; 2026Q1: 15,000 shares; 2026Q2: 15,000 shares; 2026Q3: 18,000 shares 18,000$5.4M3.09%+3,000Timeline
AAGILENT TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 35,000 shares; 2025Q1: 50,000 shares; 2025Q2: 45,000 shares; 2025Q3: 33,000 shares; 2025Q4: 35,000 shares; 2026Q1: 30,000 shares; 2026Q2: 30,000 shares; 2026Q3: 30,000 shares 30,000$5.17M2.95%0Timeline
CNCCENTENE CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 80,000 shares 80,000$4.97M2.84%newTimeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 15,000 shares; 2025Q1: 9,000 shares; 2025Q2: 11,000 shares; 2025Q3: 10,000 shares; 2025Q4: 7,000 shares; 2026Q1: 5,000 shares; 2026Q2: 5,000 shares; 2026Q3: 4,230 shares 4,230$4.89M2.8%-770Timeline
EHCENCOMPASS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 45,000 shares; 2025Q1: 51,600 shares; 2025Q2: 25,000 shares; 2025Q3: 35,000 shares; 2025Q4: 50,000 shares; 2026Q1: 15,000 shares; 2026Q2: 15,000 shares; 2026Q3: 40,000 shares 40,000$4.86M2.78%+25,000Timeline
RVTYREVVITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 45,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 30,000 shares 30,000$4.59M2.62%newTimeline
WATWATERS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 14,000 shares; 2025Q1: 17,000 shares; 2025Q2: 18,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 15,000 shares; 2026Q2: 15,000 shares; 2026Q3: 10,000 shares 10,000$4.39M2.51%-5,000Timeline
BRKRBRUKER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 60,000 shares; 2025Q4: 65,000 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 65,000 shares 65,000$4.21M2.4%newTimeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 50,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 35,000 shares; 2026Q1: 20,000 shares; 2026Q2: 20,000 shares; 2026Q3: 45,000 shares 45,000$3.88M2.22%+25,000Timeline
MDTMEDTRONIC PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 75,000 shares; 2025Q2: 80,000 shares; 2025Q3: 60,000 shares; 2025Q4: 45,000 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 45,000 shares 45,000$3.88M2.22%newTimeline
RGENREPLIGEN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,000 shares; 2025Q1: not reported; 2025Q2: 30,000 shares; 2025Q3: 27,500 shares; 2025Q4: 25,000 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 20,000 shares 20,000$3.84M2.2%newTimeline
MTDMETTLER TOLEDO INTERNATIONALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,000 shares; 2026Q1: 2,750 shares; 2026Q2: 2,750 shares; 2026Q3: 2,500 shares 2,500$3.78M2.16%-250Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 40,000 shares; 2025Q2: 50,000 shares; 2025Q3: not reported; 2025Q4: 25,000 shares; 2026Q1: 25,000 shares; 2026Q2: 25,000 shares; 2026Q3: 25,000 shares 25,000$3.73M2.13%0Timeline
CITHE CIGNA GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,000 shares; 2025Q1: 12,500 shares; 2025Q2: 16,500 shares; 2025Q3: 14,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 13,203 shares 13,203$3.59M2.05%newTimeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 15,000 shares; 2026Q2: 15,000 shares; 2026Q3: 15,000 shares 15,000$3.39M1.94%0Timeline
BIOBIO RAD LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,000 shares; 2025Q1: not reported; 2025Q2: 18,000 shares; 2025Q3: 11,000 shares; 2025Q4: 12,000 shares; 2026Q1: 10,000 shares; 2026Q2: 10,000 shares; 2026Q3: 8,000 shares 8,000$3.02M1.73%-2,000Timeline
AVTRAVANTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 200,000 shares; 2025Q1: 200,000 shares; 2025Q2: 225,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 175,000 shares 175,000$2.63M1.5%newTimeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 15,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 22,000 shares 22,000$2.16M1.24%newTimeline
MRNAMODERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,000 shares 10,000$1.93M1.1%newTimeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 2,500 shares; 2025Q3: not reported; 2025Q4: 1,500 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,000 shares 2,000$1.92M1.1%newTimeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 5,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,500 shares 2,500$1.26M0.72%newTimeline
TWSTTWIST BIOSCIENCE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,128 shares 1,128$218K0.12%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CALL- BSX 100 @ 75 EXP 04/…CALL- BSX 100 @ 75 EXP 04/17/2026800$5.02Mshares
ISRGINTUITIVE SURGICAL INC9,000$4.15Mshares
AZNASTRAZENECA PLC20,000$3.94Mshares
BSXBOSTON SCIENTIFIC CORP62,000$3.89Mshares
THCTENET HEALTHCARE CORP20,000$3.77Mshares
SYKSTRYKER CORPORATION10,000$3.29Mshares
UHSUNIVERSAL HLTH SVCS INC17,500$3.13Mshares
REGNREGENERON PHARMACEUTICALS4,000$3.09Mshares
GMEDGLOBUS MED INC30,000$2.58Mshares
SNNSMITH & NEPHEW PLC50,000$1.59Mshares
CVSCVS HEALTH CORP20,000$1.44Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001596452-26-000008 base2026-10-13

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001596452-26-000008 Quarter ended 2026-09-302026-10-13
13F-HR 0001596452-26-000004 Quarter ended 2026-06-302026-07-20acceptance time not in the bulk data set
13F-HR 0001596452-26-000003 Quarter ended 2026-03-312026-04-15acceptance time not in the bulk data set
13F-HR 0001596452-26-000002 Quarter ended 2025-12-312026-01-21acceptance time not in the bulk data set
13F-HR 0001596452-25-000011 Quarter ended 2025-09-302025-10-23acceptance time not in the bulk data set
13F-HR 0001596452-25-000007 Quarter ended 2025-06-302025-07-25acceptance time not in the bulk data set
13F-HR 0001596452-25-000006 Quarter ended 2025-03-312025-04-22acceptance time not in the bulk data set
13F-HR 0001596452-25-000003 Quarter ended 2024-12-312025-01-23acceptance time not in the bulk data set
13F-HR 0001596452-24-000008 Quarter ended 2024-09-302024-11-06acceptance time not in the bulk data set
13F-HR 0001596452-24-000005 Quarter ended 2024-06-302024-07-29acceptance time not in the bulk data set
13F-HR 0001596452-24-000004 Quarter ended 2024-03-312024-05-01acceptance time not in the bulk data set
13F-HR 0001596452-24-000003 Quarter ended 2023-12-312024-02-05acceptance time not in the bulk data set
13F-HR 0001596452-23-000006 Quarter ended 2023-09-302023-11-07acceptance time not in the bulk data set
13F-HR 0001596452-23-000005 Quarter ended 2023-06-302023-08-09acceptance time not in the bulk data set
13F-HR 0001596452-23-000004 Quarter ended 2023-03-312023-05-08acceptance time not in the bulk data set
13F-HR 0001596452-23-000003 Quarter ended 2022-12-312023-02-08acceptance time not in the bulk data set
13F-HR 0001596452-22-000007 Quarter ended 2022-09-302022-11-04acceptance time not in the bulk data set
13F-HR 0001596452-22-000005 Quarter ended 2022-06-302022-08-10acceptance time not in the bulk data set
13F-HR 0001596452-22-000004 Quarter ended 2022-03-312022-05-09acceptance time not in the bulk data set
13F-HR 0001596452-22-000002 Quarter ended 2021-12-312022-02-08acceptance time not in the bulk data set
13F-HR 0001596452-21-000009 Quarter ended 2021-09-302021-11-12acceptance time not in the bulk data set
13F-HR 0001596452-21-000006 Quarter ended 2021-06-302021-08-10acceptance time not in the bulk data set
13F-HR 0001596452-21-000004 Quarter ended 2021-03-312021-05-12acceptance time not in the bulk data set
13F-HR 0001596452-21-000001 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR 0001596452-20-000006 Quarter ended 2020-09-302020-11-13acceptance time not in the bulk data set
13F-HR 0001596452-20-000005 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-HR 0001596452-20-000004 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-HR 0001596452-20-000003 Quarter ended 2019-12-312020-02-13acceptance time not in the bulk data set
13F-HR 0001398344-19-019529 Quarter ended 2019-09-302019-11-12acceptance time not in the bulk data set
13F-HR 0001398344-19-014277 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR 0001398344-19-008193 Quarter ended 2019-03-312019-05-08acceptance time not in the bulk data set
13F-HR 0001398344-19-002462 Quarter ended 2018-12-312019-02-12acceptance time not in the bulk data set
13F-HR 0001398344-18-016303 Quarter ended 2018-09-302018-11-13acceptance time not in the bulk data set
13F-HR 0001398344-18-011281 Quarter ended 2018-06-302018-08-06acceptance time not in the bulk data set
13F-HR 0001398344-18-007078 Quarter ended 2018-03-312018-05-08acceptance time not in the bulk data set
13F-HR 0001398344-18-001711 Quarter ended 2017-12-312018-02-08acceptance time not in the bulk data set
13F-HR 0001398344-17-014373 Quarter ended 2017-09-302017-11-08acceptance time not in the bulk data set
13F-HR 0001398344-17-010090 Quarter ended 2017-06-302017-08-11acceptance time not in the bulk data set
13F-HR 0001398344-17-006221 Quarter ended 2017-03-312017-05-11acceptance time not in the bulk data set
13F-HR 0001398344-17-001862 Quarter ended 2016-12-312017-02-13acceptance time not in the bulk data set
13F-HR 0001398344-16-020624 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR 0001398344-16-016131 Quarter ended 2016-06-302016-08-05acceptance time not in the bulk data set
13F-HR 0001398344-16-012969 Quarter ended 2016-03-312016-05-06acceptance time not in the bulk data set
13F-HR 0001398344-16-009587 Quarter ended 2015-12-312016-02-05acceptance time not in the bulk data set
13F-HR 0001398344-15-007340 Quarter ended 2015-09-302015-11-04acceptance time not in the bulk data set
13F-HR 0001398344-15-004268 Quarter ended 2015-06-302015-07-06acceptance time not in the bulk data set
13F-HR 0001398344-15-002269 Quarter ended 2015-03-312015-04-01acceptance time not in the bulk data set
13F-HR 0001398344-15-000059 Quarter ended 2014-12-312015-01-07acceptance time not in the bulk data set
13F-HR 0001398344-14-005164 Quarter ended 2014-09-302014-10-03acceptance time not in the bulk data set
13F-HR 0001398344-14-003455 Quarter ended 2014-06-302014-07-03acceptance time not in the bulk data set
13F-HR 0001398344-14-002108 Quarter ended 2014-03-312014-04-10acceptance time not in the bulk data set
13F-HR 0001398344-14-000215 Quarter ended 2013-12-312014-01-10acceptance time not in the bulk data set